- 20th February 2020 at 4:13 pm #19277Michael MortonKeymaster
Since we wrote our article on the 18th February about the performance of Novacyt shares on the back of their successful Coronavirus test, the share price has fallen dramatically.
I thought Stuart made a great point about this stock being a hedge against the virus, particularly in light of its performance as the big headlines spooked the financial markets. News of Covid-19 has left the front pages of late and the markets have regained the ground they lost.
— The Armchair Trader (@armchairtweets) February 24, 2020
We don’t know yet if the Coronavirus will escalate, or disappear as we head in to spring. So I’m keeping a few shares for now, as a hedge against the worst case scenario. I’d rather lose money than see things escalate, but the investment is there just in case.
- You must be logged in to reply to this topic.